Celanese (NYSE:CE) -4.7% in Friday's trading to its lowest in more than four years after Piper Sandler downgrades shares to ...

Fastly (FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped its ...

Piper Sandler analyst Harsh Kumar raised the firm’s price target on Nvidia (NVDA) to $175 from $140 and keeps an Overweight rating on the ...

Nvidia (NVDA) was in the spotlight on Monday as Piper Sandler named the semiconductor giant its top large-cap pick. Read for more.

Investing.com - Nvidia (NASDAQ:NVDA) is "well-positioned" to capture most of the expected growth in the market for specialized artificial intelligence-enhancing hardware in 2025, analysts at Piper ...

Piper Sandler raised the firm’s price target on ACV Auctions (ACVA) to $18 from $16 and keeps a Neutral rating on the shares following ...

Expectations for President-elect Donald Trump to roll out expansionary fiscal policies and extend U.S. economic ...

Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...

On Tuesday, Piper Sandler maintained its optimistic stance on shares of Zura Bio Ltd. (NASDAQ: ZURA), reiterating an Overweight rating with a $26.00 price target. The firm's confidence in Zura Bio ...

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for ...

Piper Sandler analysts on Thursday cut their rating on HubSpot (NYSE:HUBS) shares to Neutral from Overweight, while raising ...

Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering development of regulatory RNAs as a novel therapeutic ...